Halozyme Therapeutics (HALO) PT Lowered to $71 at JMP Securities
Tweet Send to a Friend
(Updated - May 8, 2024 4:52 AM EDT)
JMP Securities analyst Jason Butler lowered the price target on Halozyme ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JMP Securities analyst Jason Butler lowered the price target on Halozyme ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
